1. Home
  2. FFIC vs HQL Comparison

FFIC vs HQL Comparison

Compare FFIC & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFIC
  • HQL
  • Stock Information
  • Founded
  • FFIC 1929
  • HQL 1992
  • Country
  • FFIC United States
  • HQL United States
  • Employees
  • FFIC N/A
  • HQL N/A
  • Industry
  • FFIC Major Banks
  • HQL Investment Managers
  • Sector
  • FFIC Finance
  • HQL Finance
  • Exchange
  • FFIC Nasdaq
  • HQL Nasdaq
  • Market Cap
  • FFIC 415.1M
  • HQL 368.7M
  • IPO Year
  • FFIC 1995
  • HQL N/A
  • Fundamental
  • Price
  • FFIC $11.86
  • HQL $12.58
  • Analyst Decision
  • FFIC Hold
  • HQL
  • Analyst Count
  • FFIC 3
  • HQL 0
  • Target Price
  • FFIC $16.17
  • HQL N/A
  • AVG Volume (30 Days)
  • FFIC 163.2K
  • HQL 120.9K
  • Earning Date
  • FFIC 07-28-2025
  • HQL 01-01-0001
  • Dividend Yield
  • FFIC 7.32%
  • HQL 11.56%
  • EPS Growth
  • FFIC N/A
  • HQL N/A
  • EPS
  • FFIC N/A
  • HQL 0.79
  • Revenue
  • FFIC $124,028,000.00
  • HQL N/A
  • Revenue This Year
  • FFIC $112.30
  • HQL N/A
  • Revenue Next Year
  • FFIC $7.61
  • HQL N/A
  • P/E Ratio
  • FFIC N/A
  • HQL $17.08
  • Revenue Growth
  • FFIC N/A
  • HQL N/A
  • 52 Week Low
  • FFIC $10.65
  • HQL $11.34
  • 52 Week High
  • FFIC $18.59
  • HQL $14.37
  • Technical
  • Relative Strength Index (RSI)
  • FFIC 41.29
  • HQL 53.42
  • Support Level
  • FFIC $11.83
  • HQL $12.12
  • Resistance Level
  • FFIC $12.34
  • HQL $12.73
  • Average True Range (ATR)
  • FFIC 0.27
  • HQL 0.22
  • MACD
  • FFIC -0.07
  • HQL 0.03
  • Stochastic Oscillator
  • FFIC 5.08
  • HQL 67.21

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.

Share on Social Networks: